PDB Short entry for 1UUM HEADER OXIDOREDUCTASE 06-JAN-04 1UUM TITLE RAT DIHYDROOROTATE DEHYDROGENASE (DHOD)IN COMPLEX WITH ATOVAQUONE CAVEAT 1UUM AFI A 400 HAS WRONG CHIRALITY AT ATOM C16 AFI B 400 HAS CAVEAT 2 1UUM WRONG CHIRALITY AT ATOM C16 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROOROTATE DEHYDROGENASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: MITOCHONDRIAL PRECURSOR, DIHYDROOROTATE OXIDASE, DHODEHASE; COMPND 5 EC: 1.3.99.11; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS RATTUS; SOURCE 3 ORGANISM_COMMON: BLACK RAT, ROOF RAT; SOURCE 4 ORGANISM_TAXID: 10117; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS OXIDOREDUCTASE, DIHYDROOROTATE DEHYDROGENASE, BREQUINAR, ATOVAQUONE, KEYWDS 2 NUCLEOTIDE METABOLISM, PYRIMIDINE BIOSYNTHESIS, FAD, FLAVOPROTEIN, KEYWDS 3 TRANSIT PEPTIDE EXPDTA X-RAY DIFFRACTION AUTHOR M.HANSEN,J.LE NOURS,E.JOHANSSON,T.ANTAL,A.ULLRICH,M.LOFFLER,S.LARSEN REVDAT 6 29-JUL-20 1UUM 1 CAVEAT COMPND REMARK HETNAM REVDAT 6 2 1 SITE REVDAT 5 24-JUL-19 1UUM 1 REMARK REVDAT 4 10-JUL-19 1UUM 1 REMARK REVDAT 3 30-JAN-19 1UUM 1 REMARK REVDAT 2 24-FEB-09 1UUM 1 VERSN REVDAT 1 01-APR-04 1UUM 0 JRNL AUTH M.HANSEN,J.LE NOURS,E.JOHANSSON,T.ANTAL,A.ULLRICH,M.LOFFLER, JRNL AUTH 2 S.LARSEN JRNL TITL INHIBITOR BINDING IN A CLASS 2 DIHYDROOROTATE DEHYDROGENASE JRNL TITL 2 CAUSES VARIATIONS IN THE MEMBRANE-ASSOCIATED N-TERMINAL JRNL TITL 3 DOMAIN JRNL REF PROTEIN SCI. V. 13 1031 2004 JRNL REFN ISSN 0961-8368 JRNL PMID 15044733 JRNL DOI 10.1110/PS.03533004 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 43995 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2183 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6937 REMARK 3 BIN R VALUE (WORKING SET) : 0.2550 REMARK 3 BIN FREE R VALUE : 0.2840 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 332 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5316 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 176 REMARK 3 SOLVENT ATOMS : 205 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.22000 REMARK 3 B22 (A**2) : -0.22000 REMARK 3 B33 (A**2) : 0.44000 REMARK 3 B12 (A**2) : 2.35000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.17 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.24 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.890 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.280 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.040 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.110 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.060 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 37.19 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : LIGAND_NEW.PAR REMARK 3 PARAMETER FILE 4 : WATER.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : LIGAND_NEW.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1UUM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-JAN-04. REMARK 100 THE DEPOSITION ID IS D_1290014318. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-AUG-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : BW7A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9999 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44018 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.30600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOUR DIFFUSION HANGING DROP WITH REMARK 280 MOTHER LIQUOR, 5% PEG400, 1.9 M AMMONIUM SULPHATE, 0.1 M TRIS- REMARK 280 HCL PH 8.6, PROTEIN SOLUTION: 15 MG/ML PROTEIN, 2 MM OROTATE, REMARK 280 0.1 % BETA-OCTYLGLUCOSIDE, 0.1 MM ATOVAQUONE, PH 8.50, VAPOR REMARK 280 DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CATALYTIC ACTIVITY: (S)-DIHYDROOROTATE + O2 = OROTATE + H2O2 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 25 REMARK 465 HIS A 26 REMARK 465 HIS A 27 REMARK 465 HIS A 28 REMARK 465 HIS A 29 REMARK 465 HIS A 30 REMARK 465 ALA A 31 REMARK 465 THR A 32 REMARK 465 GLY A 33 REMARK 465 ASP A 34 REMARK 465 ASP A 35 REMARK 465 HIS A 36 REMARK 465 PHE A 37 REMARK 465 PRO A 216 REMARK 465 ASN A 217 REMARK 465 THR A 218 REMARK 465 ALA A 219 REMARK 465 GLY A 220 REMARK 465 LEU A 221 REMARK 465 ARG A 222 REMARK 465 SER A 223 REMARK 465 LEU A 224 REMARK 465 HIS B 25 REMARK 465 HIS B 26 REMARK 465 HIS B 27 REMARK 465 HIS B 28 REMARK 465 HIS B 29 REMARK 465 HIS B 30 REMARK 465 ALA B 31 REMARK 465 THR B 32 REMARK 465 GLY B 33 REMARK 465 ASP B 34 REMARK 465 ASP B 35 REMARK 465 HIS B 36 REMARK 465 PHE B 37 REMARK 465 PRO B 216 REMARK 465 ASN B 217 REMARK 465 THR B 218 REMARK 465 ALA B 219 REMARK 465 GLY B 220 REMARK 465 LEU B 221 REMARK 465 ARG B 222 REMARK 465 SER B 223 REMARK 465 LEU B 224 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 248 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 248 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 41 -57.04 79.89 REMARK 500 ARG A 146 54.22 -142.63 REMARK 500 VAL A 213 23.34 -142.85 REMARK 500 THR A 283 107.39 90.85 REMARK 500 TYR A 356 -68.20 -144.82 REMARK 500 ALA B 39 -70.68 -46.09 REMARK 500 TYR B 41 -57.24 82.05 REMARK 500 ARG B 146 54.45 -144.48 REMARK 500 VAL B 213 23.18 -141.79 REMARK 500 THR B 283 106.82 90.65 REMARK 500 TYR B 356 -67.27 -146.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 8-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 9-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 THE SHEETS PRESENTED AS "BB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 8-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 9-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UUO RELATED DB: PDB REMARK 900 RAT DIHYDROOROTATE DEHYDROGENASE (DHOD)IN COMPLEX WITH BREQUINAR REMARK 999 REMARK 999 SEQUENCE REMARK 999 29 FIRST RESIDUES IN N-TERMINAL DELETED AND HIS-TAQ ADDED DBREF 1UUM A 25 30 PDB 1UUM 1UUM 25 30 DBREF 1UUM A 31 396 UNP Q63707 PYRD_RAT 30 395 DBREF 1UUM B 25 30 PDB 1UUM 1UUM 25 30 DBREF 1UUM B 31 396 UNP Q63707 PYRD_RAT 30 395 SEQRES 1 A 372 HIS HIS HIS HIS HIS HIS ALA THR GLY ASP ASP HIS PHE SEQRES 2 A 372 TYR ALA GLU TYR LEU MET PRO GLY LEU GLN ARG LEU LEU SEQRES 3 A 372 ASP PRO GLU SER ALA HIS ARG LEU ALA VAL ARG VAL THR SEQRES 4 A 372 SER LEU GLY LEU LEU PRO ARG ALA THR PHE GLN ASP SER SEQRES 5 A 372 ASP MET LEU GLU VAL LYS VAL LEU GLY HIS LYS PHE ARG SEQRES 6 A 372 ASN PRO VAL GLY ILE ALA ALA GLY PHE ASP LYS ASN GLY SEQRES 7 A 372 GLU ALA VAL ASP GLY LEU TYR LYS LEU GLY PHE GLY PHE SEQRES 8 A 372 VAL GLU VAL GLY SER VAL THR PRO GLN PRO GLN GLU GLY SEQRES 9 A 372 ASN PRO ARG PRO ARG VAL PHE ARG LEU PRO GLU ASP GLN SEQRES 10 A 372 ALA VAL ILE ASN ARG TYR GLY PHE ASN SER HIS GLY LEU SEQRES 11 A 372 SER VAL VAL GLU HIS ARG LEU ARG ALA ARG GLN GLN LYS SEQRES 12 A 372 GLN ALA GLN LEU THR ALA ASP GLY LEU PRO LEU GLY ILE SEQRES 13 A 372 ASN LEU GLY LYS ASN LYS THR SER GLU ASP ALA ALA ALA SEQRES 14 A 372 ASP TYR ALA GLU GLY VAL ARG THR LEU GLY PRO LEU ALA SEQRES 15 A 372 ASP TYR LEU VAL VAL ASN VAL SER SER PRO ASN THR ALA SEQRES 16 A 372 GLY LEU ARG SER LEU GLN GLY LYS THR GLU LEU ARG HIS SEQRES 17 A 372 LEU LEU SER LYS VAL LEU GLN GLU ARG ASP ALA LEU LYS SEQRES 18 A 372 GLY THR ARG LYS PRO ALA VAL LEU VAL LYS ILE ALA PRO SEQRES 19 A 372 ASP LEU THR ALA GLN ASP LYS GLU ASP ILE ALA SER VAL SEQRES 20 A 372 ALA ARG GLU LEU GLY ILE ASP GLY LEU ILE VAL THR ASN SEQRES 21 A 372 THR THR VAL SER ARG PRO VAL GLY LEU GLN GLY ALA LEU SEQRES 22 A 372 ARG SER GLU THR GLY GLY LEU SER GLY LYS PRO LEU ARG SEQRES 23 A 372 ASP LEU SER THR GLN THR ILE ARG GLU MET TYR ALA LEU SEQRES 24 A 372 THR GLN GLY ARG ILE PRO ILE ILE GLY VAL GLY GLY VAL SEQRES 25 A 372 SER SER GLY GLN ASP ALA LEU GLU LYS ILE GLN ALA GLY SEQRES 26 A 372 ALA SER LEU VAL GLN LEU TYR THR ALA LEU ILE PHE LEU SEQRES 27 A 372 GLY PRO PRO VAL VAL VAL ARG VAL LYS ARG GLU LEU GLU SEQRES 28 A 372 ALA LEU LEU LYS GLU ARG GLY PHE THR THR VAL THR ASP SEQRES 29 A 372 ALA ILE GLY ALA ASP HIS ARG ARG SEQRES 1 B 372 HIS HIS HIS HIS HIS HIS ALA THR GLY ASP ASP HIS PHE SEQRES 2 B 372 TYR ALA GLU TYR LEU MET PRO GLY LEU GLN ARG LEU LEU SEQRES 3 B 372 ASP PRO GLU SER ALA HIS ARG LEU ALA VAL ARG VAL THR SEQRES 4 B 372 SER LEU GLY LEU LEU PRO ARG ALA THR PHE GLN ASP SER SEQRES 5 B 372 ASP MET LEU GLU VAL LYS VAL LEU GLY HIS LYS PHE ARG SEQRES 6 B 372 ASN PRO VAL GLY ILE ALA ALA GLY PHE ASP LYS ASN GLY SEQRES 7 B 372 GLU ALA VAL ASP GLY LEU TYR LYS LEU GLY PHE GLY PHE SEQRES 8 B 372 VAL GLU VAL GLY SER VAL THR PRO GLN PRO GLN GLU GLY SEQRES 9 B 372 ASN PRO ARG PRO ARG VAL PHE ARG LEU PRO GLU ASP GLN SEQRES 10 B 372 ALA VAL ILE ASN ARG TYR GLY PHE ASN SER HIS GLY LEU SEQRES 11 B 372 SER VAL VAL GLU HIS ARG LEU ARG ALA ARG GLN GLN LYS SEQRES 12 B 372 GLN ALA GLN LEU THR ALA ASP GLY LEU PRO LEU GLY ILE SEQRES 13 B 372 ASN LEU GLY LYS ASN LYS THR SER GLU ASP ALA ALA ALA SEQRES 14 B 372 ASP TYR ALA GLU GLY VAL ARG THR LEU GLY PRO LEU ALA SEQRES 15 B 372 ASP TYR LEU VAL VAL ASN VAL SER SER PRO ASN THR ALA SEQRES 16 B 372 GLY LEU ARG SER LEU GLN GLY LYS THR GLU LEU ARG HIS SEQRES 17 B 372 LEU LEU SER LYS VAL LEU GLN GLU ARG ASP ALA LEU LYS SEQRES 18 B 372 GLY THR ARG LYS PRO ALA VAL LEU VAL LYS ILE ALA PRO SEQRES 19 B 372 ASP LEU THR ALA GLN ASP LYS GLU ASP ILE ALA SER VAL SEQRES 20 B 372 ALA ARG GLU LEU GLY ILE ASP GLY LEU ILE VAL THR ASN SEQRES 21 B 372 THR THR VAL SER ARG PRO VAL GLY LEU GLN GLY ALA LEU SEQRES 22 B 372 ARG SER GLU THR GLY GLY LEU SER GLY LYS PRO LEU ARG SEQRES 23 B 372 ASP LEU SER THR GLN THR ILE ARG GLU MET TYR ALA LEU SEQRES 24 B 372 THR GLN GLY ARG ILE PRO ILE ILE GLY VAL GLY GLY VAL SEQRES 25 B 372 SER SER GLY GLN ASP ALA LEU GLU LYS ILE GLN ALA GLY SEQRES 26 B 372 ALA SER LEU VAL GLN LEU TYR THR ALA LEU ILE PHE LEU SEQRES 27 B 372 GLY PRO PRO VAL VAL VAL ARG VAL LYS ARG GLU LEU GLU SEQRES 28 B 372 ALA LEU LEU LYS GLU ARG GLY PHE THR THR VAL THR ASP SEQRES 29 B 372 ALA ILE GLY ALA ASP HIS ARG ARG HET FMN A 398 31 HET ORO A 399 11 HET AFI A 400 26 HET BOG A 401 20 HET FMN B 398 31 HET ORO B 399 11 HET AFI B 400 26 HET BOG B 401 20 HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM ORO OROTIC ACID HETNAM AFI 2-[4-(4-CHLOROPHENYL)CYCLOHEXYLIDENE]-3,4-DIHYDROXY- HETNAM 2 AFI 1(2H)-NAPHTHALENONE HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE HETSYN FMN RIBOFLAVIN MONOPHOSPHATE FORMUL 3 FMN 2(C17 H21 N4 O9 P) FORMUL 4 ORO 2(C5 H4 N2 O4) FORMUL 5 AFI 2(C22 H19 CL O3) FORMUL 6 BOG 2(C14 H28 O6) FORMUL 11 HOH *205(H2 O) HELIX 1 1 TYR A 38 LEU A 50 1 13 HELIX 2 2 ASP A 51 LEU A 65 1 15 HELIX 3 3 SER A 76 GLU A 80 5 5 HELIX 4 4 ALA A 104 LEU A 111 1 8 HELIX 5 5 PRO A 138 ASP A 140 5 3 HELIX 6 6 GLY A 153 ALA A 163 1 11 HELIX 7 7 ARG A 164 ASP A 174 1 11 HELIX 8 8 ASP A 190 GLY A 203 1 14 HELIX 9 9 PRO A 204 ALA A 206 5 3 HELIX 10 10 GLY A 226 ALA A 243 1 18 HELIX 11 11 THR A 261 GLY A 276 1 16 HELIX 12 12 GLY A 295 GLU A 300 5 6 HELIX 13 13 LEU A 309 THR A 324 1 16 HELIX 14 14 SER A 338 GLY A 349 1 12 HELIX 15 15 TYR A 356 GLY A 363 1 8 HELIX 16 16 PRO A 365 ARG A 381 1 17 HELIX 17 17 THR A 385 ILE A 390 1 6 HELIX 18 18 GLY A 391 ARG A 395 5 5 HELIX 19 19 TYR B 38 LEU B 50 1 13 HELIX 20 20 ASP B 51 LEU B 65 1 15 HELIX 21 21 SER B 76 GLU B 80 5 5 HELIX 22 22 ALA B 104 LEU B 111 1 8 HELIX 23 23 PRO B 138 ASP B 140 5 3 HELIX 24 24 GLY B 153 ARG B 164 1 12 HELIX 25 25 ARG B 164 ASP B 174 1 11 HELIX 26 26 ASP B 190 GLY B 203 1 14 HELIX 27 27 PRO B 204 ALA B 206 5 3 HELIX 28 28 GLY B 226 ALA B 243 1 18 HELIX 29 29 THR B 261 GLY B 276 1 16 HELIX 30 30 GLY B 295 GLU B 300 5 6 HELIX 31 31 LEU B 309 THR B 324 1 16 HELIX 32 32 SER B 338 GLY B 349 1 12 HELIX 33 33 TYR B 356 GLY B 363 1 8 HELIX 34 34 PRO B 365 ARG B 381 1 17 HELIX 35 35 THR B 385 ILE B 390 1 6 HELIX 36 36 GLY B 391 ARG B 395 5 5 SHEET 1 AA 2 VAL A 81 VAL A 83 0 SHEET 2 AA 2 HIS A 86 PHE A 88 -1 O HIS A 86 N VAL A 83 SHEET 1 AB 9 VAL A 92 ILE A 94 0 SHEET 2 AB 9 ALA A 350 LEU A 355 1 O VAL A 353 N GLY A 93 SHEET 3 AB 9 ILE A 330 VAL A 333 1 O ILE A 330 N SER A 351 SHEET 4 AB 9 GLY A 279 VAL A 282 1 O LEU A 280 N ILE A 331 SHEET 5 AB 9 ALA A 251 ILE A 256 1 O VAL A 254 N ILE A 281 SHEET 6 AB 9 TYR A 208 ASN A 212 1 O LEU A 209 N LEU A 253 SHEET 7 AB 9 LEU A 178 LEU A 182 1 O ILE A 180 N VAL A 210 SHEET 8 AB 9 PHE A 115 VAL A 121 1 O VAL A 116 N GLY A 179 SHEET 9 AB 9 VAL A 92 ILE A 94 1 O ILE A 94 N GLU A 117 SHEET 1 AC 3 VAL A 134 LEU A 137 0 SHEET 2 AC 3 ALA A 142 ASN A 145 -1 O ALA A 142 N LEU A 137 SHEET 3 AC 3 GLY A 303 GLY A 306 -1 O GLY A 303 N ASN A 145 SHEET 1 BA 2 VAL B 81 VAL B 83 0 SHEET 2 BA 2 HIS B 86 PHE B 88 -1 O HIS B 86 N VAL B 83 SHEET 1 BB 9 VAL B 92 ILE B 94 0 SHEET 2 BB 9 ALA B 350 LEU B 355 1 O VAL B 353 N GLY B 93 SHEET 3 BB 9 ILE B 330 VAL B 333 1 O ILE B 330 N SER B 351 SHEET 4 BB 9 GLY B 279 VAL B 282 1 O LEU B 280 N ILE B 331 SHEET 5 BB 9 ALA B 251 ILE B 256 1 O VAL B 254 N ILE B 281 SHEET 6 BB 9 TYR B 208 ASN B 212 1 O LEU B 209 N LEU B 253 SHEET 7 BB 9 LEU B 178 LEU B 182 1 O ILE B 180 N VAL B 210 SHEET 8 BB 9 PHE B 115 VAL B 121 1 O VAL B 116 N GLY B 179 SHEET 9 BB 9 VAL B 92 ILE B 94 1 O ILE B 94 N GLU B 117 SHEET 1 BC 3 VAL B 134 LEU B 137 0 SHEET 2 BC 3 ALA B 142 ASN B 145 -1 O ALA B 142 N LEU B 137 SHEET 3 BC 3 GLY B 303 GLY B 306 -1 O GLY B 303 N ASN B 145 CISPEP 1 ARG A 131 PRO A 132 0 -0.26 CISPEP 2 ARG B 131 PRO B 132 0 -0.11 CRYST1 133.150 133.150 50.130 90.00 90.00 120.00 P 3 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007510 0.004336 0.000000 0.00000 SCALE2 0.000000 0.008672 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019948 0.00000 MTRIX1 1 0.500000 0.866000 0.000000 -66.57247 1 MTRIX2 1 -0.866000 0.500000 0.000000 115.32687 1 MTRIX3 1 0.000000 0.000000 1.000000 75.21201 1